REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas. - Picca A; Touat M; Belin L; Gourmelon C; Harlay V; Cuzzubbo S; Cohen-Jonathan Moyal E; Bronnimann C; Di Stefano AL; Laurent I; Lerond J; Carpentier C; et al. (European journal of cancer (Oxford, England : 1990), 2024)